Skip to main content
Fig. 6 | Journal of Hematology & Oncology

Fig. 6

From: Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Fig. 6

Somatic mutation frequency and comparison of somatic mutation frequency between responders and non-responders. Data show the percentage of samples with somatic mutations on our 91-gene panel; gray bars indicate non-responders, black bars indicate responders. **p value < 0.01, comparison of PIK3CA mutation frequency between responders and non-responders

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us